Home
Law & policy

Law & policy

Prospect of European SEP regulation looms large in US policy debate

During a recent Washington DC event, SEP holders and standards implementers clashed about the European Commission’s draft proposal – and how the US should respond

Innovator-implementer divide revealed to US policymakers considering IP, standards strategy

Standards contributors stressed their heavy reliance on licensing income while product manufacturers expressed frustration at the difficulty of calculating total SEP licensing costs

Start-ups can gain design protection faster with new accelerated examination programme

TIPO’s new pilot programme allows certain applicants to swiftly secure protection for their design patents, facilitates rapid responses to counterfeit designs and assists award winners and start-ups to obtain patent rights.

Latest content

US government confirms concerns over EC SEP licensing regulation

Commerce Secretary Gina Raimondo reveals that officials have told Brussels of worries about aspects of the proposed legislation

04 May 2023

There is still time for a rethink on the EU’s proposed SEP licensing regulation

Fiery language aimed at patent holders by DG Grow chief Thierry Breton cannot mask the lack of evidence supporting the need for legislation

04 May 2023

Moderna’s ongoing struggles over covid infringement liability have broader implications

The vaccine maker has suffered another setback, but its fight to deflect infringement responsibility to the US government continues

02 May 2023

Some gold nuggets for patentees in the PTAB reform proposal

Saturday Opinion: Discretionary denial of IPRs with co-pending litigation will benefit IP owners but some provisions contradict statutory authority

29 April 2023

US PTAB reform proposal comes under fire at House hearing

Congress members grilled USPTO Director Kathi Vidal for rule-making proposals that they view as outside the statutory authority of the America Invents Act

28 April 2023

European Commission proposes unitary SPC as part of mixed bag of pharma IP reforms

Planned change will make UPC more attractive to life sciences companies

28 April 2023

Commissioner Breton takes aim at “bad faith” patent licensors as final SEP policy proposal released

Vague provision to exempt certain ‘use cases’ from the new framework last-minute addition

27 April 2023

Chinese IP theft is a problem, but is not to blame for US tech woes

Until policy makers in Washington DC fully recognise the extent of the self-harm that has been done to American interests, serious recovery is a forlorn hope

27 April 2023

PTAB experts react to discretionary denial reform package

Various provisions in the USPTO’s rulemaking proposal favour patent owners and others lean towards petitioners, yet one thing is certain: chief IP officers must make their voices heard

26 April 2023

IP court annual report breaks down valuable statistics on appeals cases

China’s Supreme Court’s IP branch has released its 2022 annual report, providing statistics on caseload and closure. These numbers highlight the longer wait times for appeals, as well as varying chances of success.

26 April 2023

Unlock unlimited access to all IAM content